EC quorum SOP – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Sat, 23 Aug 2025 08:01:33 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 How to Develop SOPs for Institutional Ethics Committees https://www.clinicalstudies.in/how-to-develop-sops-for-institutional-ethics-committees/ Sat, 23 Aug 2025 08:01:33 +0000 https://www.clinicalstudies.in/?p=6524 Read More “How to Develop SOPs for Institutional Ethics Committees” »

]]>
How to Develop SOPs for Institutional Ethics Committees

Step-by-Step Guide to Creating SOPs for Institutional Ethics Committees

Introduction: Why SOPs Are Crucial for Ethics Committees

Standard Operating Procedures (SOPs) are foundational documents that govern the operations of Institutional Ethics Committees (IECs) or Institutional Review Boards (IRBs). SOPs not only ensure consistency, regulatory compliance, and quality assurance but also establish transparency in decision-making processes. Without clear SOPs, ECs are vulnerable to deviations, regulatory findings, and ethical lapses—especially in multicenter, multinational trials.

International agencies like ANZCTR, WHO, ICMR, and AAHRPP emphasize documented procedures as a precondition for EC credibility and accreditation. This article outlines how to draft, review, and implement SOPs aligned with ICH-GCP, local regulations, and accreditation guidelines.

Core Components of an EC SOP Framework

A comprehensive set of SOPs for an ethics committee must cover all key functions and operational domains. These include but are not limited to:

  • Constitution and Composition of the EC
  • Initial and Continuing Review Processes
  • Review of Protocol Amendments and Serious Adverse Events (SAEs)
  • Expedited and Emergency Reviews
  • Conflict of Interest Management
  • Quorum Requirements and Meeting Protocols
  • Record Keeping and Archival
  • Member Training and Evaluation

Each SOP should begin with a clear title, purpose, scope, responsibilities, procedure steps, and associated templates/forms.

Step 1: SOP on EC Constitution and Roles

This SOP outlines the eligibility, selection process, and roles of members. It defines the ideal mix of scientific and non-scientific members, laypersons, legal experts, and gender representation.

Role Minimum Number Qualification
Clinician (Chairperson) 1 MBBS/MD, external to institution
Legal Expert 1 LLB/LLM or experience in medico-legal matters
Layperson 1 Non-scientific, independent member

The SOP should also define tenure, renewal of membership, and frequency of reconstitution.

Step 2: SOP for Protocol Review Process

This SOP must describe how study protocols are received, allocated, and reviewed. Key elements include:

  • Checklist for submission completeness
  • Distribution of protocol to primary and secondary reviewers
  • Review timelines (usually 21–30 days)
  • Decision-making criteria (approval, conditional approval, rejection)

The SOP should reference ICH-GCP E6(R2) standards and define documentation procedures for minutes, vote counts, and dissent opinions.

Step 3: SOP for Expedited and Emergency Review

This SOP applies to minimal risk studies, SAE follow-ups, and protocol deviations. It must define:

  • What qualifies for expedited review (e.g., observational studies, minor amendments)
  • Timelines for review (usually 5–10 days)
  • Reviewer responsibility and documentation

A sample clause could be: “Expedited review decisions must be ratified at the next full board meeting.”

Step 4: SOP for Handling Serious Adverse Events (SAEs)

The EC must receive and review SAE reports promptly. This SOP should define:

  • Timelines: initial report within 24 hours; full report within 14 days
  • SAE review committee constitution
  • Reporting to DCGI (India) or relevant authority

It should also explain how to assess causality, severity, and protocol violation linkage.

Step 5: SOP on Conflict of Interest and Quorum

Each EC SOP manual must contain a standalone section on identifying and managing conflicts of interest (COI). This should include:

  • Declaration forms for members
  • Recusal procedures during protocol discussion
  • Documentation of COI in meeting minutes

Quorum SOP should specify minimum members and mandatory presence of at least one layperson and one member from a non-affiliated institution.

Step 6: SOP on Record Retention and Documentation

This SOP defines how EC records are stored, accessed, and archived. Key points include:

  • Retention period: minimum of 3–5 years post-study closure
  • Access controls and audit trails
  • Backup procedures and disaster recovery plans

Digital recordkeeping systems should be compliant with 21 CFR Part 11 (if used).

Step 7: SOP on Member Training and Capacity Building

Ongoing competency of EC members is vital. This SOP should include:

  • Initial orientation covering ICH-GCP, Schedule Y, and local laws
  • Annual training and documentation
  • Assessment through quizzes or audit feedback

Sample training log fields: Date, Topic, Trainer, Signature, Evaluation Result.

Best Practices for SOP Development and Review

Follow these best practices to ensure quality and regulatory compliance:

  • Involve multidisciplinary EC members in SOP drafting
  • Use version control with effective and superseded dates
  • Include flowcharts and decision trees for complex procedures
  • Establish annual SOP review and revision cycle

Challenges in SOP Implementation and How to Overcome Them

Common hurdles include lack of buy-in, resistance to documentation, and SOP overload. Address these through:

  • Training sessions emphasizing the role of SOPs in protecting trial subjects
  • Templates and SOP writing workshops
  • Creating a SOP compliance dashboard for audit readiness

Conclusion: SOPs as the Backbone of EC Accountability

Developing and implementing SOPs for Institutional Ethics Committees is not just a regulatory checkbox—it’s a commitment to ethical rigor and procedural fairness. SOPs empower ECs to operate transparently, review protocols consistently, and safeguard participant rights effectively. With proper structure, periodic review, and institutional support, SOPs become living documents that elevate the credibility of the ethics review process in every clinical trial setting.

]]>
SOP for EC Quorum and Conflict of Interest Handling https://www.clinicalstudies.in/sop-for-ec-quorum-and-conflict-of-interest-handling/ Fri, 08 Aug 2025 19:23:20 +0000 ]]> https://www.clinicalstudies.in/sop-for-ec-quorum-and-conflict-of-interest-handling/ Read More “SOP for EC Quorum and Conflict of Interest Handling” »

]]>
SOP for EC Quorum and Conflict of Interest Handling

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-EC-Quorum-and-Conflict-of-Interest-Handling”
},
“headline”: “SOP for Ethics Committee Quorum and Conflict of Interest Handling”,
“description”: “This SOP describes regulatory-compliant procedures for managing Ethics Committee (EC)/IRB quorum requirements and handling conflicts of interest, in alignment with ICH GCP, WHO, FDA, EMA, and CDSCO standards.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for EC Quorum and Conflict of Interest Handling

Department Clinical Research
SOP No. CR/ETH/009/2025
Supersedes NA
Page No. 1 of 20
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to define the procedures for ensuring that Ethics Committee (EC)/Institutional Review Board (IRB) meetings meet quorum requirements and for managing conflicts of interest (COI) among members. This guarantees unbiased decision-making, participant safety, and compliance with international and local regulatory requirements.

Scope

This SOP applies to all EC/IRB members, secretariat staff, investigators, and sponsors involved in clinical trials reviewed by the EC/IRB. It covers quorum establishment, conflict of interest disclosure, member recusal, documentation, and record-keeping.

Responsibilities

  • EC/IRB Chairperson: Ensures quorum is met before review or approval of any protocol and manages COI declarations.
  • EC/IRB Secretariat: Maintains attendance logs, COI declarations, and meeting minutes.
  • EC/IRB Members: Disclose any conflict of interest prior to participation in protocol review.
  • Quality Assurance Officer: Verifies compliance with quorum and COI handling requirements.
  • Head of Clinical Research: Oversees adherence to SOP at institutional level.

Accountability

The EC/IRB Chairperson is accountable for ensuring that all meetings adhere to quorum and COI handling requirements. Any deviation may render decisions invalid and result in regulatory non-compliance.

Procedure

1. Quorum Requirements
A quorum is defined as at least 5 voting members, including at least one lay person, one member with medical/scientific expertise, and one member independent of the institution (as per ICH GCP and national guidelines).
Meetings without quorum shall be rescheduled; decisions made without quorum are invalid.

2. Attendance Recording
EC/IRB Secretariat records attendance at each meeting.
Attendance log must include name, designation, role (voting/non-voting), and signature.

3. Conflict of Interest (COI) Disclosure
All members must declare COI before discussion of any protocol where they have financial, academic, or personal interest.
Declarations must be documented in the COI Register (Annexure-2).

4. COI Management
Members with COI shall leave the meeting room during discussion and decision-making.
Their absence and recusal must be recorded in meeting minutes.

5. Documentation and Record Keeping
Secretariat files attendance logs, COI declarations, and minutes in EC/IRB records.
Records are archived in compliance with ICH GCP and local requirements.

Abbreviations

  • SOP: Standard Operating Procedure
  • EC: Ethics Committee
  • IRB: Institutional Review Board
  • COI: Conflict of Interest
  • ICH: International Council for Harmonisation
  • GCP: Good Clinical Practice
  • QA: Quality Assurance

Documents

  1. EC/IRB Attendance Log (Annexure-1)
  2. Conflict of Interest Declaration Register (Annexure-2)
  3. EC/IRB Meeting Minutes Template (Annexure-3)

References

  • ICH E6(R2) Good Clinical Practice
  • US FDA 21 CFR Part 56 – IRB Requirements
  • EMA Clinical Trial Regulation (EU No. 536/2014)
  • WHO Operational Guidelines for Ethics Committees
  • CDSCO Clinical Trial Rules, India (2019)

Version: 1.0

Approval Section

Prepared By Rajesh Kumar, EC/IRB Secretariat Officer
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, EC/IRB Chairperson

Annexures

Annexure-1: EC/IRB Attendance Log

Date Member Name Designation Role Signature
05/09/2025 Dr. Meera Joshi Clinician Voting Signed
05/09/2025 Mr. Ravi Kumar Lay Member Voting Signed

Annexure-2: Conflict of Interest Declaration Register

Date Member Name Protocol No. Declared Interest Action Taken
05/09/2025 Dr. Anil Sharma CTP-2025-05 Consultant for sponsor Recused

Annexure-3: EC/IRB Meeting Minutes Template

Date Protocol No. Discussion Summary Decision Remarks
05/09/2025 CTP-2025-05 Protocol reviewed, quorum achieved Approved With condition: SAE reporting within 24 hrs

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head, Clinical Research

For more SOPs visit: Pharma SOP

]]>